Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

$20.5m for sleep disorder co

This article was originally published in Clinica

Executive Summary

Sleep Solutions has secured $20.5m in new capital in a financing round led by the TPG Biotechnology II fund. The investment will be used to establish a US sales and marketing infrastructure and to advance development of new applications of the Sleep Solutions' home-based diagnostic system for obstructive sleep apnoea (OSA). The Pasadena, Maryland company's NovaSom QSG device, combined with the MediTrack patient management system, allows OSA patients to be monitored at home, thereby reducing the high costs of carrying out overnight sleep centre studies. According to Sleep Soltuions, the OSA diagnostic testing market is projected to exceed $3bn in 2008 and grow 20-30% annually for the next five years.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT046409

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel